Save time and get answers to complex questions with AI chat
Brenzavvy discontinuation?Guselkumab brand name?Defense strategy against generic in niche market?Patent term adjustment semaglutida?Tracleer online pharmacy?
See the DrugPatentWatch profile for secukinumab
Yes. Secukinumab is a biologic medicine. It is a monoclonal antibody designed to target interleukin-17A (IL-17A), a protein involved in inflammatory pathways.
Secukinumab is a fully human monoclonal antibody (rather than a small-molecule pill). That means it’s produced using biological systems and is given by injection.
It’s typically administered as a subcutaneous injection (with dosing schedules depending on the condition being treated).
Other Questions About Secukinumab :